Meeting
2019 ASCO Annual Meeting
Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
Authors
Arlindo R. Ferreira
Institut Gustave Roussy, Villejuif, France
Arlindo R. Ferreira , Antonio Di Meglio , Barbara Pistilli , Arnauld S. Gbenou , Mayssam El-Mouhebb , Sibille Everhard , Charles Coutant , Paul-Henri Cottu , Florence Lerebours , Thierry Petit , Florence Dalenc , Philippe Rouanet , Antoine Arnaud , Anne-Laure Martin , Patricia A. Ganz , Ann H. Partridge , Suzette Delaloge , Stefan Michiels , Fabrice Andre , Ines Maria Vaz Duarte Luis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 37, 2019 (suppl; abstr 512)
DOI
10.1200/JCO.2019.37.15_suppl.512
Abstract #
512
Poster Bd #
4
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi
Poster
2023 ASCO Annual Meeting
Long-term longitudinal patterns of patient-reported quality of life (QOL) after breast cancer (BC) to inform the implementation of personalized pathways of care.
First Author: Maria Alice B Franzoi
Poster
2015 Breast Cancer Symposium
Voice of Cancer Patients: Analysis of patient concerns regarding cognitive deficits associated with treatment for breast cancer.
First Author: Sangeeta Aggarwal
First Author: Juerg Bernhard